Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022343731> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W2022343731 abstract "Background and Objective: This short -term .....se control study of 70 consecutively recruited HIV-infected and previously antiretroviral naive patients, treated with a combination therapy of stavudine, lamivudine and nevirapine (case) and 30 HIV-infected patients who were yet to start therapy (controls) were studied to evaluate the effect of highly active antiretroviral therapy (HAART) on the haematological parameters of HIV infected individuals. Methodology: Haematological parameters of haemoglobin, total with cell count, platelet count, erythrocyte sedimentation rate and differentia/leucocyte count were determined at baseline for subjects and control patients. Subjects were placed on HAART (stavudine 40 mg, lamivudine 150mg and nevirapine 200mg) twice daily for twelve weeks. of haematological parameters was repeated after 12 weeks of HAART in subjects and untreated controls. Result: The occurrence of anaemia, neutropenia, thrombocytopenia and leucopenia obtained respectively at baseline was 84.3%, 24.3%, 11.4% and 11.4% for subjects but after 12 weeks of HAART these declined respectively to75.7%, 7.1%, 5.7% and 1.4%. Comparatively, there was an increase from baseline values of 96.7%, 23.3%, 6.7% and6.7% to 100%, 36.7%, 10% and 36.7% respectively in untreated controls. The difference in mean haematological values of subjects and controls at baseline was not statistically significant (p < O.OS). But after 12 weeks of HAART in subjects and observation in untreated controls, the difference in mean haemaglobin (t = 5.77, p < 0.05), platelet count (I= 2.25, p < 0.05) and erythrocyte sedimentation rate (t = -3.20 p < 0.05) became statistically significant. While the haemoglobin, platelet and erythrocyte sedimentation rate improved in subjects, it declined in untreated controls. Conclusion: This study clearly indicates that highly active antiretroviral therapy of two reverse transcriptaseinhibitors (stavudine and lamivudine) and one noll -nucleoside reverse transcriptase inhibitor (nevirapine) may improvecytopenios in HIV-infected Nigerians and may be used in patients with haematologic intolerance to other regimen." @default.
- W2022343731 created "2016-06-24" @default.
- W2022343731 creator A5059514258 @default.
- W2022343731 creator A5064019360 @default.
- W2022343731 date "2005-12-03" @default.
- W2022343731 modified "2023-10-16" @default.
- W2022343731 title "The effects of highly active antiretroviral therapy on the haemotological profile of HIV-infected Africans: the Nigerian perspective" @default.
- W2022343731 doi "https://doi.org/10.4314/smj2.v8i2.12893" @default.
- W2022343731 hasPublicationYear "2005" @default.
- W2022343731 type Work @default.
- W2022343731 sameAs 2022343731 @default.
- W2022343731 citedByCount "0" @default.
- W2022343731 crossrefType "journal-article" @default.
- W2022343731 hasAuthorship W2022343731A5059514258 @default.
- W2022343731 hasAuthorship W2022343731A5064019360 @default.
- W2022343731 hasConcept C126322002 @default.
- W2022343731 hasConcept C142462285 @default.
- W2022343731 hasConcept C203014093 @default.
- W2022343731 hasConcept C2522874641 @default.
- W2022343731 hasConcept C2776694085 @default.
- W2022343731 hasConcept C2777063308 @default.
- W2022343731 hasConcept C2777869810 @default.
- W2022343731 hasConcept C2778143017 @default.
- W2022343731 hasConcept C2779130552 @default.
- W2022343731 hasConcept C2779889181 @default.
- W2022343731 hasConcept C2780593183 @default.
- W2022343731 hasConcept C2993143319 @default.
- W2022343731 hasConcept C3013748606 @default.
- W2022343731 hasConcept C71924100 @default.
- W2022343731 hasConcept C90924648 @default.
- W2022343731 hasConceptScore W2022343731C126322002 @default.
- W2022343731 hasConceptScore W2022343731C142462285 @default.
- W2022343731 hasConceptScore W2022343731C203014093 @default.
- W2022343731 hasConceptScore W2022343731C2522874641 @default.
- W2022343731 hasConceptScore W2022343731C2776694085 @default.
- W2022343731 hasConceptScore W2022343731C2777063308 @default.
- W2022343731 hasConceptScore W2022343731C2777869810 @default.
- W2022343731 hasConceptScore W2022343731C2778143017 @default.
- W2022343731 hasConceptScore W2022343731C2779130552 @default.
- W2022343731 hasConceptScore W2022343731C2779889181 @default.
- W2022343731 hasConceptScore W2022343731C2780593183 @default.
- W2022343731 hasConceptScore W2022343731C2993143319 @default.
- W2022343731 hasConceptScore W2022343731C3013748606 @default.
- W2022343731 hasConceptScore W2022343731C71924100 @default.
- W2022343731 hasConceptScore W2022343731C90924648 @default.
- W2022343731 hasLocation W20223437311 @default.
- W2022343731 hasOpenAccess W2022343731 @default.
- W2022343731 hasPrimaryLocation W20223437311 @default.
- W2022343731 hasRelatedWork W113335921 @default.
- W2022343731 hasRelatedWork W1999633340 @default.
- W2022343731 hasRelatedWork W2077294588 @default.
- W2022343731 hasRelatedWork W2368730810 @default.
- W2022343731 hasRelatedWork W2605308547 @default.
- W2022343731 hasRelatedWork W2616770481 @default.
- W2022343731 hasRelatedWork W2752253408 @default.
- W2022343731 hasRelatedWork W148066406 @default.
- W2022343731 hasRelatedWork W2596317807 @default.
- W2022343731 hasRelatedWork W3151353973 @default.
- W2022343731 isParatext "false" @default.
- W2022343731 isRetracted "false" @default.
- W2022343731 magId "2022343731" @default.
- W2022343731 workType "article" @default.